AstraZeneca executive: 'The vaccine is clearly effective'

Mene Pangalos, a senior executive at AstraZeneca, says he hopes a vaccine developed with Oxford University will "get us back to normal".

Large-scale trials show the vaccine offers 70% protection against the virus, and is significantly cheaper than the ones developed by Pfizer and Moderna, which offer a 90% success rate.